# Filing Detail

Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001140361-23-047255
Filing Date
2023-10-06
Accepted
2023-10-06 08:08:24
Documents
1
Period of Report
2022-12-31
Effectiveness Date
2023-10-06

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ARS | ny20010238x3_ars.pdf | ARS | 606406
| Complete submission text file | 0001140361-23-047255.txt |  | 836639

Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

EIN.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-31791 | Film No.: 231312642
SIC: 2834 Pharmaceutical Preparations